Skip to Content

    An aggressive shopping spree for early-stage drugs helped this biotech firm more than double its revenues since 2010.

    41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

    Company Information

    Location
    La Jolla, CA
    Industry
    Pharmaceuticals
    Sector
    Health Care
    Fortune 500 Rank-
    Fortune 500 Profile-
    Current Streak2
    Years on List2
    CEO
    John L. Higgins
    Websitehttp://www.ligand.com

    Revenue, Net Income

    Revenue Past Four Quarters63
    Net Income Past Four Quarters11

    Growth Rates

    EPS 3 yr Annual Growth Rate43%
    Rev 3 yr Annual Growth Rate31%
    Total Return 3 yr Annual Rate81%
    Beat S&P 3 yr Total Return?
    yes

    Rank

    EPS Growth Rank55
    Revenue Growth Rank41
    Total Return Rank
    9